grafted cells in BM ranged from 23% to 78% for recipients of normal donor marrow and from 0.1 % to 39% for recipients of 5-FU marrow. Mean engraftment for 6 mice receiving normal marrow was 38%, whereas that for 6 mice receiving post-5-FU marrow was 8%. as assayed 1 to 3 months posttransplant. At 10 to 12 months, mean engraftment for the normal donor group was 46%. compared with 16% for the 5-FU group. The patterns of engraftment with normal and 5-FU marrow were similar for spleen and thymus. These results show that long-term chimerism can be established after transplantation of normal donor marrow to normal nonirradiated host mice and indicate that marrow spaces do not have to be created for successful engraftment. They suggest that transplanted marrow competes equally with host marrow for marrow space. Finally, these data show that post-5-FU Balb/C male marrow is markedly inferior in the repopulation of Balb/C female host marrow, spleen, and thymus, and suggest that this population of cells may not be the ideal population for gene transfer studies.
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differs dramatically from the normal intramedullary environment. Little is known about the effects on marrow engraftment or long-term renewal of the intramedullary alterations seen with myeloablation and whether their influence may be positive or negative.
In a similar vein, there is virtually no information on engraftment and renewal of different marrow cell populations in normal noncytoablated hosts. Marrow from mice subjected to 5-fluorouracil (5-FU) treatment enriched in certain classes of candidate marrow renewal cells, such as the high proliferative potential colony-forming cell (HPP-CFC), rapidly renews hematopoiesis in irradiated host mice7 and, because of its relative increase in proliferating progenitors, has been used as a target cell population for gene tran~fer.'.~ Post-5-FU marrow is equal or superior to normal marrow in engraftment and renewal capacity in irradiated host mice," but whether post-5-FU marrow shows a similar repopulating advantage in nonirradiated hosts had not been previously addressed.
The present study evaluates the capacity of normal and post-5-FU murine marrow to engraft and persist in normal nonirradiated host mice.
MATERIALS AND METHODS
Transplantation of normal murine marrow to normal untreated hosts. Six-to 8-week-old BDF-I, CBA-J, or BALB/C female mice were injected intravenously by tail vein daily for 5 consecutive days with 40 X lo6 male cells or with phosphate-buffered saline (PBS).
Volumes for injection were the same in each experiment and ranged from 0.5 to I . O mL. The percentage of male marrow in marrow cells was then determined at varying times posttransplant using a chromosome banding (c-banding) technique to identify the Y chromosome' or Southern blot analysis with the Y-chromosomespecific pY2 probe courtesy of Dr Ihor Lemischka (Princeton University, Princeton, NJ)" (see below). Southern blot analysis was also used to assess the percentage of male DNA in spleen, thymus, liver, and muscle. 
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Male BALB/C mice were injected with 5-FU (150 mg/kg) intravenously and marrow was harvested 6 days later. The equivalent, calculated on a volume basis, of two tibias and two femurs from post-5-FU or from normal control BALB/C mice was then injected into host female mice daily for 5 consecutive days. 5-FU injections to donor mice were staggered over 5 days so that 6-day post-5-FU marrow was transplanted each day. Southern blot analysis was then performed using the pY2 probe.
Cytogenetic analysis. Marrow cells were incubated in 50% Fischer's media with 15% fetal calf serum (FCS) and 50% supematant of the murine stromal cell line TC-1 I' for 24 hours, as this procedure had been shown in preliminary experiments to increase the metaphase yield. The cells were then washed and resuspended in prewarmed (37°C) RPMI, 15% FCS, 1% penicillin-streptomycin, and 2 pg colcemid in a volume of 10 mL and incubated at 37°C for 2 hours. The cells were then washed and suspended in 0.25 mol/L KCl for 45 minutes, followed by three washes and resuspensions in Carnoy's fixative, chilling once for 15 minutes, and a repeat fixative change. A Pasteur pipette was used to drop the fixative-cell suspension onto wet slides from a height of 6 inches and slides were then allowed to air dry. They were then incubated for I hour at room temperature in 0.25N HC1, rinsed and incubated in Ba(OH), solution for 1.5 to 2.0 minutes, rinsed and incubated in 2X SSC (0.3 mol/L NaCl and 0.03 mol/L trisodium citrate) at 60°C for 1 hour, and rinsed and finally stained with Giemsa. The Y chromosome was identified by lack of heterochromatic staining at the centromere.
DNA extracts of murine marrow, spleen, thymus, liver, and muscle were prepared by lysis in 0. I5 mol/L NaCl, 0.02 mol/L Tris, 0.02 mol/L EDTA, 1% sodium dodecyl sulfate (SDS), followed by purification using organic extraction with proteinase K, pancreatic RNAse, and phenol-chloroform and precipitation in ethanol." DNA samples were analyzed for the presence of Y-specific sequences using the pY2 cDNA probe. These samples were digested with the restriction enzymes Dra I and BamHI and the digests s e p arated by gel electrophoresis in 0.8% agarose. Equal amounts of digested DNA, as determined by 260/280 ratios, were loaded per gel and the comparability of loaded DNA was determined by reprobing membranes with a partial-or full-length cDNA for interleukin-3 (IL-3; courtesy of J. Ihle and DNAX, Palo Alto, CA). The DNA fragments were transferred from the gel onto Zetaprobe nylon membranes (BioRad, Richmond, CA) according to established Southem blotting techniques. The pY2 probe was labeled with 32P using a random primer labeling kit (Boehringer Mannheim, Mannheim, Germany); hybridization with Zetaprobe membranes was performed in 10% dextran sulfate, 1% SDS, 1X Denhardt's, 4X SSCP at 65°C for 18 to 22 hours. Autoradiography was performed using Kodak XRP xray film with or without enhancing screens (Eastman Kodak, Rochester, NY) at -70°C for varying time intervals. The percentage of male DNA was calculated based on densitometry comparisons between posttransplant DNA samples and male murine DNA. Densitometry was performed on an LKB ultrascan XL enhanced laser densitometer (LKB Pharmacia, Uppsala, Sweden). Calculations of percent DNA were adjusted based on amounts of DNA loaded on each gel as estimated by densitometry of IG3-probed Southem blots.
Using these techniques and mixing male and female DNA, we can detect 3% but not 1 ' % male DNA in a mixture. B and T cells were separated from spleen cell suspensions obtained from mice receiving transplants at 10 and 12 months posttransplantation by antibody panning. Falcon 100 X 15 mm plates (Becton Dickinson, Mountain View, CA) were coated with either goat antimouse Ig or goat antirat Ig-nonabsorbed (Southem Biotechnology Associates, Birmingham, AL) at I mg/mL, in 5 mL of 0.05 mol/L Tris-HC1, pH 9.5. After 1 hour of incubation at room temperature, the plates were stored on Southern blot analysis.
Analysis of individual cell populations. a level surface overnight at 4°C. The goat antimouse plates were gently washed three times with 5 mL of PBS and then incubated for 1 hour at 4°C with 5 X lo6 spleen cells. The goat antirat plates were gently washed three times with PBS followed by the addition of 50 fiL of 14.8 monoclonal antibody (to give 100 &plate) in 3 mL of PBS. These plates were incubated for 10 minutes at room temperature and for 20 minutes at 4"C, washed with PBS, and then used to pan the nonadherent spleen cells from goat antimouse plates (1 hour at 4°C). Pre-B and B cells in the adherent fraction from each panning were lysed in 5 mL DNA isolation buffer, 0.15 mol/L NaCl, 0.02 mol/L Tris, 0.02 mol/L EDTA, and 1% SDS and the lysates combined. T cells isolated from the nonadherent fraction of the 14.8 pan were carefully removed, centrifuged at 1,200 rpm, and then resuspended in 10 mL of DNA isolation buffer. When reanalyzed by flow cytometry, using CD4 and CD8 with or without CD5 as markers, this nonadherent population was 71% to 93% T cells and I% to 2% B cells. Dexter stromal culture^'^^'^ were established from explant marrow from one femur and one tibia harvested from mice 10 and 12 months after transplantation. These cultures, grown in Fischer's medium with 20% horse serum and lo-' mol/L hydrocortisone, were demidepopulated weekly. After 3 weeks of culture, the supernatants, containing granulocytes, macrophages, megakaryocytes, and rare progenitorlstem cells, were collected and DNA isolated as outlined above. The depopulated Dexter culture stromal layer was then exposed to 1,100 R, washed, and cultured for 1 additional week at week 4; the stromal adherent layer was lysed with DNA isolation buffer and DNA isolated (vide supra). This adherent stromal layer consists predominantly of macrophages and preadipocytic fibroblasts.
Differences between 5-FU and normal groups were determined using the Student's t-test. Linear regression analysis was determined using the Medlog program (Information Analysis, Mountain View, CA).
Statistics.

RESULTS
Male marrow from BALB/c, BDF-1, or CBA mice when injected into female mice of the same strain evidences successful engraftment at from 2 to 36 weeks after the 5 days of injections. T h e percentage of male marrow cells was determined by analyzing metaphase spreads for the presence of the Y chromosome and ranged from 5% to 46% (Table I) . For
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The mean percentage of engraftment of male marrow cells for 8 BALB/C mice at 2 to 6 weeks posttransplantation was 13.95% -t I. 1 TO; that for 2 BDF-I mice (pooled cells from 2 mice) at 12 weeks was 46%; and that for 4 CBA mice at 36 weeks was 6.5% 2 0.6%. These data, especially the diminished engraftment for the CBA mice. suggest that there may be genetic differences between strains in the capacity to repopulate nonmyeloablated marrow.
Female mice receiving transplants of40 million male cells per day for 5 days (as above) were killed 21 to 25 months after transplantation and analyzed for male cell engraftment in different tissues using Southern blot analysis and the pY2 cDNA probe (Fig I) . Persistence of engrafted male marrow in host female marrow was observed at 2 1 to 25 months after transplantation. Similar results were obtained when host splenic tissue was analyzed from the same mice (data not shown). Host female thymus also showed persistence of engrafted male cells at 25 months posttransplantation (3 mice, 0.3%, 2.8%, and 51% engraftment, respectively; data not shown). Evidence for male sequence in female liver DNA was clearly seen in mice X and B, barely detectable in mouse Y , and not seen in mice A and Z. Muscle was also analyzed in 3 mice (data not shown) and showed no evidence of male sequence. All blots were reprobed with IL-3 cDNA to determine load accuracy and densitometry values were then corrected for load error based on IL-3 densitometry values.
The percentage of engraftment, as determined by densitometry, in marrow at 2 I to 25 months ranged from 15% to 42% (Fig 1) and the percentage of engraftment in spleen gave similar results (data not shown).
We have also assessed engraftment at different cell levels and injection schedules. We have injected 30 X IO6 or 40 X IO6 normal male Balb/C cells into normal female hosts once and grafts were then analyzed by pY2 hybridization at 7 weeks and 6 months; there was no evidence of engraftment. We also injected 5 X IO6 cells daily for 5 days and analyzed pY2 hybridization marrow DNA at 2,4, 6, and 64 weeks; again, no engraftment was detected.
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Comparison of normal and post-5-FU male marrow transplantation into normal ,female hosts. Equal amounts of marrow, calculated on a volume rather than cell number basis (tibia/femur equivalents), from normal mice or mice treated 6 days previously with 5-FU were transplanted by tail vein injection into normal nonmyeloablated host female mice 1, 2, 3, IO, and 12 months before killing and analysis of organs for male DNA. The mean percentage of male DNA in mice receiving normal marrow as detected by pY2 probe hybridization and Southern blot analysis at 1, 2, 3, IO, and 12 months posttransplantation was 38%, 3296, 45% 42% and 48%, respectively. The mean percentage of male DNA in marrow from mice receiving post-5-FU marrow was markedly decreased as compared with that of mice receiving normal marrow. At 1, 2, 3, 10, and 12 months. the mean percent engraftments for post-5-FU marrow were I %, 10%. 1 I%, 18%, and 1470, respectively. The differences between 5-FU and normal marrow for I -to 3-month and IO-to 12-month intervals were statistically significant at a P value of <.01 (two-tailed). Similar patterns of engraftment of male cells were seen in splenic and thymic tissue (Fig 2 and Table   Engraftment for marrow and thymus and marrow and spleen showed significant correlations (r = .69, P < .OW1 and r = .43, P = .029, respectively), whereas spleen and thymus did not significantly correlate (r = .36, P = .063).
Different subpopulations of host cells were assessed IO and 12 months after transplantation in the same experiments presented in Fig 2 and Table 2 . Dexter culture supernatant cells'(predominant1y granulocytes and macrophages, with a few megakaryocytes) showed the same pattern of engraftment as was seen with whole marrow (Fig 3) . Similar results were seen with irradiated Dexter stroma (predominantly macrophages and preadipocytic fibroblasts) and B cells (mixtures of panned IgG-positive and 14.8-positive cells) (Fig 3) . The nonadherent T-cell component of spleen cells also showed similar patterns of pY2 hybridization, but for unclear reasons we obtained incomplete digestion of the 5-FU groups (data not shown).
DISCUSSION
Successful syngeneic or autologous transplantation of bone marrow requires homing of progenitor/stem cells to marrow, initial establishment of residence or engraftment, and persistence of engraftment with concomitant proliferation, commitment, and differentiation. Current dogma holds that some type of cytoreductive treatment of marrow recipients is necessary to create space or open niches for transplanted marrow. Brecher et al? using Y chromosome analysis or mice weeks posttransplantation, with percent engraftment ranging from 16% to 25%, whereas Saxe et al." using similar approaches, found 0% to 16% engraftment in marrow or spleen at 4 to 6 weeks or 6 months posttransplantation. The present studies, using both c-banding and Southern blot analysis to detect the presence of male tissue in female hosts, confirm the early engraftment rates reported by Brecher et al. ' In addition, we have now shown stable engraftment of normal male marrow into normal female hosts up to 25 months posttransplantation. Analysis of marrow at 2 1 to 25 months showed 15% to 42% male DNA, whereas splenic tissue from the same mice showed a similar engraftment pattern. Male DNA was also detected in thymus of 3 mice at 25 months posttransplantation (0.3% to 5 I %).
Transfusion of 200 million cells represents approximately two-thirds of the normal complement of marrow cells per mouse and, thus, presumably two-thirds of the normal complement of stem cells. Given dilution of transplanted cells with normal host marrow, the maximum percent of male cells to be expected in host marrow (if all cells homed to marrow, engrafted and competed successfully) would be a p proximately 40%. This calculation does not take into account the fact that only a percentage ofthe transplanted cells actually seeds the marrow. Given these considerations, it appears that actual engraftment approaches or exceeds the theoretical maximum in most cases analyzed. This finding suggests that normal infused marrow not only competes equally with host marrow cells for long-term residence in marrow tissue, but frequently evidences a competitive advantage. They further suggest that "opening" niches or clearing marrow space for infused marrow may be unnecessary in marrow transplantation. These results are compatible with a model in which there are unoccupied niches available or, alternatively, one in which there is a direct competition for occupied marrow niches (Fig 4) . The present studies also indicate virtually quantitative engraftment in thymus and spleen. Thus. engraftment can occur in these tissues without cytotoxic ablative treatment.
Previous studies have indicated that marrow harvested from mice at varying time intervals after the administration of 150 mg/kg 5-FU is enriched in early stem cells such as HPP-CFC and has rapid renewal ~a p a c i t y .~. '~. '~ Studies of marrow competition using congenic models indicated that post-5-FU marrow also has long-term repopulation potential comparable with that of normal donor marrow.'" These post-5-FU marrow transplant studies were performed using irradiated hosts. The present studies using normal noncytoablated hosts indicate that post-5-FU marrow is markedly defective in establishing ongoing cell production at I to 3 months postengraftment, with the deficiency persisting at IO and 12 months. These engraftment patterns were demonstrable in spleen. marrow, and thymus and appeared to involve at least myeloid and lymphoid subpopulations. These studies d o not address whether the defect in transplantability of 5-FU marrow is related to initial engraftment problems or damage to accessory cells or marrow stem cells. However, they d o suggest that the proliferating progenitor/ stem cells, including HPP-CFC seen after 5-FU pretreatment. may not represent the critical marrow renewal cells. These data need to be considered in light of data that pretreatment of humans with 5-FU enriches human marrow for HPP-CFC" as well as enhances recovery of platelets and granulocytes posttransplantation.I9 Apparent differences between the murine model and human transplant experience may be related to dosage and schedule differences in the administration of 5-FU or. alternatively, may indicate that accelerated early recovery seen in the human setting is due to alterations in the proliferative rate of relatively differentiated marrow cells.
Stem Cell Displacement Theory
Excess NicheTheory
We have seen significant differences between engraftment efficiencies in different strains of mice. The possible speciesspecific differences between mice and humans also need to be considered.
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